協和キリンの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/11/01 | 1,984 | 1,984 | 1,961 | 1,972 | -24 | -1.2% | 1,209,200 |
2019/10/31 | 1,960 | 2,025 | 1,952 | 1,996 | +32 | +1.6% | 1,792,700 |
2019/10/30 | 2,025 | 2,055 | 1,953 | 1,964 | -93 | -4.5% | 2,326,200 |
2019/10/29 | 2,068 | 2,077 | 2,051 | 2,057 | +2 | +0.1% | 1,097,700 |
2019/10/28 | 2,058 | 2,067 | 2,043 | 2,055 | -3 | -0.1% | 925,700 |
2019/10/25 | 2,064 | 2,066 | 2,038 | 2,058 | +4 | +0.2% | 1,024,300 |
2019/10/24 | 2,055 | 2,063 | 2,047 | 2,054 | +11 | +0.5% | 1,317,900 |
2019/10/23 | 2,012 | 2,045 | 2,011 | 2,043 | +10 | +0.5% | 923,500 |
2019/10/21 | 2,020 | 2,041 | 2,020 | 2,033 | +8 | +0.4% | 521,900 |
2019/10/18 | 2,044 | 2,054 | 2,022 | 2,025 | -6 | -0.3% | 734,800 |
2019/10/17 | 2,048 | 2,053 | 2,021 | 2,031 | -6 | -0.3% | 694,000 |
2019/10/16 | 2,023 | 2,047 | 2,018 | 2,037 | +32 | +1.6% | 1,181,000 |
2019/10/15 | 1,987 | 2,015 | 1,974 | 2,005 | +43 | +2.2% | 1,202,100 |
2019/10/11 | 1,966 | 1,967 | 1,940 | 1,962 | +15 | +0.8% | 1,219,100 |
2019/10/10 | 1,941 | 1,951 | 1,922 | 1,947 | -21 | -1.1% | 944,300 |
2019/10/09 | 1,962 | 1,981 | 1,958 | 1,968 | -19 | -1% | 885,300 |
2019/10/08 | 2,000 | 2,021 | 1,984 | 1,987 | ±0 | ±0% | 1,247,100 |
2019/10/07 | 1,990 | 1,994 | 1,979 | 1,987 | -2 | -0.1% | 668,100 |
2019/10/04 | 1,981 | 2,001 | 1,948 | 1,989 | -14 | -0.7% | 1,408,500 |
2019/10/03 | 2,009 | 2,020 | 1,994 | 2,003 | -42 | -2.1% | 1,358,000 |
2019/10/02 | 2,049 | 2,073 | 2,039 | 2,045 | -25 | -1.2% | 1,602,900 |
2019/10/01 | 2,084 | 2,089 | 2,065 | 2,070 | -28 | -1.3% | 1,671,800 |
2019/09/30 | 2,097 | 2,119 | 2,074 | 2,098 | -44 | -2.1% | 1,901,400 |
2019/09/27 | 2,142 | 2,153 | 2,112 | 2,142 | -8 | -0.4% | 1,387,500 |
2019/09/26 | 2,190 | 2,202 | 2,143 | 2,150 | -51 | -2.3% | 1,734,100 |
2019/09/25 | 2,189 | 2,210 | 2,175 | 2,201 | +29 | +1.3% | 1,510,300 |
2019/09/24 | 2,145 | 2,175 | 2,142 | 2,172 | +28 | +1.3% | 1,067,900 |
2019/09/20 | 2,112 | 2,150 | 2,101 | 2,144 | +31 | +1.5% | 2,301,500 |
2019/09/19 | 2,098 | 2,130 | 2,090 | 2,113 | +33 | +1.6% | 2,056,600 |
2019/09/18 | 2,099 | 2,103 | 2,077 | 2,080 | -20 | -1% | 1,828,100 |
2019/09/17 | 2,085 | 2,117 | 2,059 | 2,100 | +45 | +2.2% | 1,678,900 |
2019/09/13 | 2,047 | 2,060 | 2,030 | 2,055 | +35 | +1.7% | 2,398,300 |
2019/09/12 | 1,990 | 2,038 | 1,988 | 2,020 | +60 | +3.1% | 1,682,400 |
2019/09/11 | 1,985 | 1,986 | 1,953 | 1,960 | -18 | -0.9% | 1,776,900 |
2019/09/10 | 2,020 | 2,033 | 1,975 | 1,978 | -42 | -2.1% | 1,163,200 |
2019/09/09 | 1,996 | 2,021 | 1,992 | 2,020 | +34 | +1.7% | 819,200 |
2019/09/06 | 1,980 | 1,992 | 1,961 | 1,986 | +19 | +1% | 1,338,000 |
2019/09/05 | 1,981 | 1,985 | 1,956 | 1,967 | -34 | -1.7% | 1,734,200 |
2019/09/04 | 1,945 | 2,006 | 1,943 | 2,001 | +70 | +3.6% | 1,581,100 |
2019/09/03 | 1,923 | 1,938 | 1,909 | 1,931 | -2 | -0.1% | 842,000 |
2019/09/02 | 1,940 | 1,946 | 1,933 | 1,933 | -12 | -0.6% | 870,200 |
2019/08/30 | 1,924 | 1,951 | 1,910 | 1,945 | +26 | +1.4% | 2,063,500 |
2019/08/29 | 1,918 | 1,927 | 1,903 | 1,919 | +10 | +0.5% | 1,397,600 |
2019/08/28 | 1,920 | 1,952 | 1,905 | 1,909 | +56 | +3% | 2,295,100 |
2019/08/27 | 1,829 | 1,855 | 1,827 | 1,853 | +33 | +1.8% | 946,400 |
2019/08/26 | 1,773 | 1,829 | 1,772 | 1,820 | -17 | -0.9% | 1,163,200 |
2019/08/23 | 1,860 | 1,873 | 1,827 | 1,837 | -17 | -0.9% | 808,700 |
2019/08/22 | 1,854 | 1,857 | 1,831 | 1,854 | +6 | +0.3% | 1,002,500 |
2019/08/21 | 1,855 | 1,865 | 1,846 | 1,848 | -20 | -1.1% | 1,095,200 |
2019/08/20 | 1,833 | 1,868 | 1,825 | 1,868 | +51 | +2.8% | 964,800 |
1351~
1400
件表示中 / 3699件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
協和キリン | 217,200円 | -3.5% | -11.3% | 2.76% | 19.95倍 | 1.34倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
アステラス薬 | 134,100円 | +0.9% | +380.2% | 5.82% | 18.47倍 | 1.59倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
塩野義 | 218,800円 | +20.9% | +10.6% | 3.02% | 10.34倍 | 1.37倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 366,700円 | +1.7% | -2.9% | 4.36% | 24.06倍 | 1.27倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
小野薬 | 149,200円 | +0.6% | +43.3% | 5.36% | 10.46倍 | 0.89倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム